Compare KNSA & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNSA | SM |
|---|---|---|
| Founded | 2015 | 1908 |
| Country | United Kingdom | United States |
| Employees | N/A | 544 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 4.5B |
| IPO Year | 2018 | 1992 |
| Metric | KNSA | SM |
|---|---|---|
| Price | $43.66 | $20.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 8 |
| Target Price | ★ $52.33 | $33.43 |
| AVG Volume (30 Days) | 671.0K | ★ 6.4M |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 6.33 |
| Revenue | $597,973,000.00 | ★ $3,166,673,000.00 |
| Revenue This Year | $62.70 | $31.11 |
| Revenue Next Year | $31.18 | $87.02 |
| P/E Ratio | $96.31 | ★ $3.01 |
| Revenue Growth | ★ 55.68 | 35.48 |
| 52 Week Low | $18.12 | $17.45 |
| 52 Week High | $45.50 | $41.29 |
| Indicator | KNSA | SM |
|---|---|---|
| Relative Strength Index (RSI) | 54.82 | 60.59 |
| Support Level | $42.99 | $18.53 |
| Resistance Level | $45.50 | $20.16 |
| Average True Range (ATR) | 1.69 | 0.88 |
| MACD | 0.28 | 0.14 |
| Stochastic Oscillator | 77.18 | 76.17 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.